Precision multidimensional assay for high-throughput microRNA drug discovery

Citations Over TimeTop 13% of 2016 papers

Abstract

Development of drug discovery assays that combine high content with throughput is challenging. Information-processing gene networks can address this challenge by integrating multiple potential targets of drug candidates' activities into a small number of informative readouts, reporting simultaneously on specific and non-specific effects. Here we show a family of networks implementing this concept in a cell-based drug discovery assay for miRNA drug targets. The networks comprise multiple modules reporting on specific effects towards an intended miRNA target, together with non-specific effects on gene expression, off-target miRNAs and RNA interference pathway. We validate the assays using known perturbations of on- and off-target miRNAs, and evaluate an ∼700 compound library in an automated screen with a follow-up on specific and non-specific hits. We further customize and validate assays for additional drug targets and non-specific inputs. Our study offers a novel framework for precision drug discovery assays applicable to diverse target families.

Related Papers

• → Keynote review: Structural biology and drug discovery(2005)336 cited
• → The use of constitutively active GPCRs in drug discovery and functional genomics(2002)109 cited
• → Functional cell-based uHTS in chemical genomic drug discovery(2002)56 cited
• → Using model-system genetics for drug-based target discovery(2001)32 cited
• → The Modular Approach to Ligand Discovery(2004)